Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 15, 2011
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Purchase
Common Shares, no par value
2011-08-11$38.62/sh+155,642$6,010,770→ 5,570,503 total
Footnotes (2)
- [F1]This number represents the weighted average purchase price with ranges purchased from $38.51 to $38.89.
- [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.